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The gel-overlay technique with 125I-labelled calmodulin allowed the detection of several calmodulin-binding proteins of Mr 280000, 150000, 97000, 56000, 35000 and 24000 in canine cardiac sarcoplasmic reticulum. Only two calmodulin-binding proteins could be identified unambiguously. Among them, the 97 000-Mr protein that undergoes phosphorylation in the presence of Ca2+ and calmodulin, is likely to be glycogen phosphorylase. In contrast, the (Ca2++Mg2+)-activated ATPase did not appear to bind calmodulin under our experimental conditions. The second known calmodulin target is dephosphophospholamban, which migrates with an apparent M, of 24000. The dimeric as well as the monomeric form of phospholamban was found to bind calmodulin. Phospholamban shifts the apparent Kd of erythrocyte (Ca2+ + Mg2+)-activated ATPase for calmodulin, suggesting thus a tight binding of calmodulin to the proteolipid. Interestingly enough, phospholamban phosphorylation by either the catalytic subunit of cyclic AMP-dependent protein kinase or the Ca2+/calmodulin-dependent phospholamban kinase was found to inhibit calmodulin binding.
Ca2+ uptake by cardiac SR is stimulated in response to either the catecholamine-triggered cyclic AMP pathway or an increase in cytosolic free Ca2+. This stimulation is associated with phosphorylation of phospholamban, a membranebound proteolipid of Mr 24000, by cyclic AMP-dependent protein kinase (Wray et al., 1973; Kirchberger et al., 1974; Planck et al., 1983) , and Ca2+/calmodulin-dependent phospholamban kinase (Le Peuch et al., 1979) . Stimulation of Ca2+ uptake by phosphorylation is correlated with (Ca2+ + Mg2+)-activated ATPase activation (Kranias et al., 1980; Tada et al., 1975) .
In addition to the indirect involvement of calmodulin in the (Ca2+ + Mg2+)-activated ATPase activation via the calmodulin-dependent phosphorylation of phospholamban, a direct interaction between the Ca2+ pump and calmodulin has been suggested (Lopaschuk et al., 1980; Mas Oliva Abbreviations used: SR, sarcoplasmic reticulum; PMSF, phenylmethanesulphonyl fluoride; DTT, dithiothreitol.
*To whom correspondence and reprint requests should be addressed. et al., 1983) . Furthermore, whereas Louis & Jarvis (1982) have reported that calmodulin binds to phospholamban, Seiler et al. (1984) have not succeeded in detecting such binding. Since calmodulin seems to play a pivotal role in the regulation of Ca2+ uptake by cardiac SR, identification of calmodulin-binding proteins in cardiac SR vesicles is a first step in the understanding of the mechanism of the Ca2+-uptake regulation.
We report here the identification of calmodulin target proteins in cardiac SR vesicles and confirm that phospholamban does bind calmodulin. In addition, its affinity for calmodulin is shown to be modulated by phosphorylation by either the cyclic AMP-dependent protein kinase or the Ca2+/calmodulin-dependent phospholamban kinase. The hypothesis that phospholamban might be either the Ca2+/calmodulin-dependent protein kinase or at least its calmodulin-binding subunit, as suggested by Louis & Jarvis (1982) Autric et al. (1980) and was iodinated to the extent of 1 mol/mol by the lodogen technique (Salacinski et al., 1981) .
Methods
Miscellaneous methods. Protein concentrations were determined by the Coomassie Blue technique using y-globulin as standard (Spector, 1978) .
Sodium dodecyl sulphate/polyacrylamide [5-20% (w/v) gradient]-gel electrophoresis was performed as described by Laemmli (1970) . Pharmacia Mr markers being used. Samples for electrophoresis were denatured in 0.25 M-DTT/2.5 M-urea/2.5% (w/v) sodium dodecyl sulphate/20mM-Tris/HCI, pH 6.8, at 4°C. Gels were dried and autoradiographed at -70°C by using an intensifying screen and Kodak Min-R films.
Densitometric scans of either Coomassie Bluestained slab gels or autoradiograms were performed by using a CS 930 Shimadzu dual-wavelength scanner.
Membrane preparations. Canine cardiac SR vesicles were prepared from dog hearts arrested in diastole by pentobarbital injection essentially as previously described (Molla et al., 1983a) . In order to remove remaining membrane-bound calmodulin, a supplementary wash in Hepes buffer, pH 7.5, containing 10mM-EDTA, was performed.
EDTA-washed red-cell membranes were prepared as described by Katz & Blostein (1975) .
Phospholamban purification. Phospholamban was extracted from freeze-dried vesicles with chloroform/methanol/12M-HCl (800:400:3, by vol.), the procedure previously described (Capony et al., 1983) being followed, except that the phosphorylation step was omitted. The extract was then purified by h.p.l.c. on a silica column packed with Spherisorb S5W obtained from Chrompack. Phospholamban was eluted by chloroform/methanol/water/trifluoroacetic acid (3000:3000:1000:7, by vol.).
Gel-overlay technique. Calmodulin binding to cardiac SR proteins was studied by the gel-overlay technique, performed essentially as described by Molla et al. (1983b) . Briefly, 300pg of protein were separated by dodecyl sulphate/polyacrylamideslab-gel electrophoresis as described above. The gel was washed in propan-2-ol/acetic acid/water, (5 :2:13, by vol.) to remove dodecyl sulphate.
Proteins were then submitted to denaturation before a renaturing step. The gel was overlaid with buffer A (0.15 M-NaCl/ 1 mM-magnesium acetate/ 1 mM-CaCl2/l mM-DTT/50mM-Tris/HCI, pH7.5) supplemented with bovine serum albumin (lOmg/ml), then soaked in buffer A containing '25I-calmodulin (240nM, 104-105 c.p.m.7/7pmol, 100 ml/slab). Unbound labelled calmodulin was removed by washing the gel in buffer A or in buffer A containing 2mM-EGTA instead of CaCl2 and magnesium acetate. The whole procedure was performed at room temperature.
Phosphorylations and dephosphorylation of SR vesicles. SR vesicle phosphorylation was carried out at 30°C in 0.1 mM-DTT/ 10mM-magnesium acetate/0.5 mM-ATP/ lOmM-NaF/30 mM-sodium phosphate buffer, pH 7.0, and either pure catalytic subunit of cyclic AMP-dependent protein kinase (enzyme/substrate ratio 1:100; specific activity 1. 16 6mol of [32 Pjphosphate incorporated/min per mg of enzyme) or 0.5pM-calmodulin in the presence of 0.1 mM-CaC12. The reaction initiated by the addition of ATP was terminated by cold trichloroacetic acid (10%, w/v) precipitation on Whatman 3MM filter papers as previously described (Molla et al., 1983a) .
Enzymic removal of bound phosphate was achieved, as described by Le Peuch et al. (1979) , by incubation at 30°C of a SR-vesicle suspension in 0.2M-sodium acetate buffer, pH5.5, with lO,ug of potato acid phosphatase (specific activity 60 units/mg). In order to monitor the extent of dephosphorylation, samples were withdrawn and pipetted on to Whatman 3 MM filter papers. The filters were washed as described by Molla et al. (1983a) were then counted for 32P radioactivity.
Red-cell (Ca2++Mg2+)-activated ATPase activity. The calmodulin-dependent (Ca2+ + Mg2+)-activated ATPase activity was measured by the amount of [32p]P; released from [y-32P]ATP as described by Katz & Blostein (1975) . The assay mixture contained 1.2mM-magnesium acetate, 240pM-[y-32 P]ATP (100 c.p.m./pmol), 144mM-KCI, 120pM-ouabain, lOOpM-CaC12 in 48mM-Hepes buffer, pH7.4, in a total volume of 6004u1.
The reaction, initiated by the addition of lOpg of membranes, was carried out at 30°C for 30min. The reaction was quenched by the addition of 0.1 ml of cold trichloroacetic acid (40%, w/v) containing 5mM-ATP and 2mM-KH2PO4. A charcoal suspension [Fischer Norit A; 1.5g/ml in the presence of 5% (w/v) trichloroacetic acid] was added, the mixture was then shaken for 5 min and then centrifuged for 5min at 3000g. The radioactivity present in the clear supernatant was determined by liquid-scintillation counting.
Results
Catalogue ofcardiac SR calmodulin-binding proteins A list of cardiac SR calmodulin-binding proteins was obtained by using gel overlay with labelled calmodulin (Fig. 1) Finally, most of the target peptides (Mr 280000, 150000, 97000 and 56000) bind calmodulin in a Ca2+-dependent manner. Most of these calmodulin proteins were also detected by using a calmodulin azido derivative (results not shown).
Among the above targets, the 97000Mr protein co-migrated with anthentic glycogen phosphorylase. The latter enzyme was shown to bind calmodulin in a Ca2+-dependent manner (Vilar Palasi et al., 1983) . It is therefore likely that the SR calmodulin-binding protein is phosphorylase b. The 56000-Mr calmodulin-binding undergoes phosphorylation in the presence of Ca2+ and calmodulin (as shown in Fig. 2 , lane 1) and co-migrates with an ATP-binding protein (results not shown). The higher-Mr target proteins were not identified. The lower-Mr labelled peptide (Mr 24000) is presumably phospholamban, since calmodulin is found to bind purified phospholamban. The dimeric (24000 Mr) as well as the monomeric (12000 Mr) form of phospholamban is detected by the calmodulin-overlay technique (Fig. 1, lane 3, and Fig. 2, lane 1) . Under our gel-electrophoresis conditions about 5-10% of the phospholamban appears to be present as the monomeric species. (Fig. 2) indicated that the labelling of the 24000-M, protein decreased when SR vesicles were phosphorylated by either the cyclic AMP-dependent protein kinase or the Ca2+/calmodulin-dependent protein kinase.
Calmodulin binding to phospholamban was quantified by monitoring the kinetics of phosphorylation of SR vesicles by either the catalytic subunit of cyclic AMP-dependent protein kinase or the Ca2+/calmodulin-dependent-protein kinase (see Fig. 3 ). Whereas the peak area ratio of 150000-Mr protein to the 280000-Mr protein was constant (around 3.3), the peak area ratio of phospholamban to the 280000-Mr protein decreased drastically when phospholamban was phosphorylated.
cis C e 4 0 This ratio fell from 4.5 for dephosphophospholamban to 0.12 and 0.45 within min of phosphorylation by the catalytic subunit of cyclic AMP-dependent protein kinase and the Ca2+-dependent endogenous kinase respectively. Furthermore, the dephosphorylation of phospholamban by potato acid phosphatase was found to increase calmodulin binding to the 24000-Mr protein (see Fig. 4 ). When SR vesicles were incubated in the presence of potato acid phosphatase, 60% of protein-bound phosphate were removed within 20min, whereas calmodulin binding to phospholamban increased and reached 58% of the maximal value. Efect of the presence of phospholamban on the activation of red-cell (Ca2+ + Mg2+)-activated ATPase by calmodulin The apparent Kd of calmodulin for the ATPase was determined to be 12nM. As shown in Fig. 5 , the apparent Kd increased to 35 nm when phospholamban was present in the assay mixture. Because this experiment was performed in a polyphasic medium, it did not allow quantification of calmodulin binding to phospholamban, but it did provide evidence for a competition for the calmodulin ligand between the ATPase and phospholamban. Effect ofphosphorylation on the affinity ofphospholamban kinase for calmodulin As shown in Fig. 6 , phosphorylation of cardiac SR vesicles by the cyclic AMP-dependent protein kinase did not modify the apparent Kd of the kinase for calmodulin. Half-maximal activation of the SR Ca2+/calmodulin-dependent kinase was 8 nm, regardless of the phosphorylation state of the vesicles. ATPase assays were performed in the presence (0) or the absence (0) of phospholamban. Freeze-dried phospholamban was suspended in chloroform/ methanol (2:1, v/v) and distributed in the assay tubes. Approx. 1 nmol of phospholamban was added in each assay. The organic solvent was then evaporated and the ATPase assay was performed as described under 'Methods' in the presence of various amounts of calmodulin. The specific activity of the enzyme was 3pmol/h per mg. (Palfrey et al., 1982) and especially in the rat heart particulate fraction does not appear to be present in dog heart SR vesicles. The 280000-Mr calmodulin target protein is perhaps identical with the high-Mr calmodulin-binding protein detected by Seiler et al. (1984) in junctional SR vesicles.
The possibility that the 30000-Mr protein which binds calmodulin, whether or not Ca2+ is present, is troponin I (Koops & Barany, 1979) Campbell & MacLennan (1983) , is therefore a possible candidate for being a subunit of phospholamban kinase.
The low-Mr target protein is assumed to be phospholamban, the SR proteolipid that was described as a 24000-Mi dimer and a 12000-Mr monomer (Le Peuch et al., 1980) . That membrane phosphorylatable proteolipids bind calmodulin is not surprising, since other substrates of cyclic AMP-dependent protein kinase, such as phosphorylase kinase, smooth-muscle myosin light-chain kinase and troponin I, also bind calmodulin (Picton et al., 1981; Conti & Adelstein, 1981; Amphlett et al., 1976 ). More recently have shown that calmodulin-binding peptides contain regions structurally similar to the recognition sequence for cyclic AMP-dependent protein kinase . Binding of calmodulin to phospholamban was shown to be inhibited after phosphorylation by either the cyclic AMP-dependent protein kinase or the Ca2+/calmodulin-dependent phospholamban kinase. Modulation of calmodulin binding after phosphorylation has also been described for smooth-muscle myosin lightchain kinase, myelin basic protein and glycogen phosphorylase (Conti & Adelstein, 1981; Vilar Palasi et al., 1983) . Phosphorylation indeed alters the hydrophobicity and charge of the calmodulin-binding site. Conversely, calmodulin binding to the site presumably prevents its phosphorylation. Preincubation of SR vesicles in the presence of calmodulin was indeed found to decrease 1.6-fold the initial velocity of phosphorylation by the catalytic subunit of cyclic AMP-dependent protein kinase (results not shown).
Calmodulin binding to phospholamban might suggest that the proteolipid is part of the Ca2+/calmodulin-dependent protein kinase undergoing autophosphorylation (Louis & Jarvis, 1982) . This possibility was dismissed, since there is no modification of the affinity of the kinase for calmodulin after phosphorylation.
It is important to note that the phospholamban phosphorylation by either cyclic AMP-or calmodulin-dependent protein kinases has identical effects, though they catalyse phosphorylation at different sites (Le Peuch et al., 1979; Louis & Jarvis, 1982) . If calmodulin does shield the phosphorylatable site(s), the cyclic AMP-dependent phosphorylation is likely to occur only in the absence of Ca2 . Conversely, the Ca2+/calmodulin-dependent phosphorylation is likely to compete with direct calmodulin-binding to phospholamban. If the above assumptions were true, one would expect the adrenaline induced cyclic AMP-dependent phosphorylation to occur mostly during diastole, when the free Ca2+ level is low enough for calmodulin to be free. Increase in the cytosolic Ca2+ concentration would allow either calmodulin binding to phospholamban and/or calmodulin-dependent phosphorylation of phospholamban.
This suggests that the two regulatory systems, triggered respectively by cyclic AMP and Ca2+, might be mutually exclusive in time.
